UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 26, 2022

Accession Number:	0001193125-22-111227
Submission Type:	POS AM
CIK: 0001833214 Company Name: SAB Biotherapeutics, Inc. File Number: 333-261496